Augmented trial designs for evaluation of principal surrogates (original) (raw)

Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model

Dean Follmann

The Annals of Applied Statistics, 2008

View PDFchevron_right

Augmented Designs to Assess Immune Response in Vaccine Trials

Dean Follmann

Biometrics, 2006

View PDFchevron_right

Assessing correlates of protection in vaccine trials

Fabian Tibaldi

The Journal of infectious diseases, 2014

View PDFchevron_right

Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post-Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials

Yannis Jemiai, Andrea Rotnitzky

Biometrics, 2006

View PDFchevron_right

Principal Surrogates in Context of High Vaccine Efficacy

Fabian Tibaldi

2019

View PDFchevron_right

Evaluating the surrogacy of multiple vaccine-induced immune response biomarkers in HIV vaccine trials

sayan dasgupta

Biostatistics, 2019

View PDFchevron_right

Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations

Ken Kleinman

Journal of Clinical Epidemiology, 2006

View PDFchevron_right

Causal inference concepts applied to three observational studies in the context of vaccine development: from theory to practice

Emmanuel Aris

BMC Medical Research Methodology

View PDFchevron_right

Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy

M. Halloran, Susmita Datta

Statistics in Medicine, 1998

View PDFchevron_right

Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies

Lone Simonsen

International Journal of Epidemiology, 2016

View PDFchevron_right

Assessing correlates of protection in vaccine trials: statistical solutions in the context of high vaccine efficacy

Fabian Tibaldi

BMC Medical Research Methodology, 2019

View PDFchevron_right

Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences

Shrijana Shrestha

PloS one, 2018

View PDFchevron_right

Sequential causal inference: application to randomized trials of adaptive treatment strategies

Philip Lavori

Statistics in medicine, 2008

View PDFchevron_right

A new endpoint definition improved clinical relevance and statistical power in a vaccine trial

Ahmadou Alioum

Journal of Clinical Epidemiology, 2009

View PDFchevron_right

Bounds on the effect of vaccine induced immune response on outcome

Dean Follmann

International Journal of Biostatistics, 2012

View PDFchevron_right

Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods

Camila Parra

Statistics in Biopharmaceutical Research

View PDFchevron_right

Principal causal effect identification and surrogate end point evaluation by multiple trials

Peng Ding

Journal of the Royal Statistical Society: Series B (Statistical Methodology), 2015

View PDFchevron_right

Bayesian Meta-Analysis to Validate Correlate of Protection for High Vaccine Efficacy Clinical Trials

EDITH UMEH

European Journal of Information Technologies and Computer Science, 2022

View PDFchevron_right

Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment

Mark Van Der Laan

Biometrika, 2011

View PDFchevron_right

A Comparison of Eight Methods for the Dual-Endpoint Evaluation of Efficacy in a Proof-of-Concept HIV Vaccine Trial

Devan Mehrotra

Biometrics, 2006

View PDFchevron_right

Estimating the population-level impact of vaccines using synthetic controls

Roger Lustig

Proceedings of the National Academy of Sciences of the United States of America, 2017

View PDFchevron_right

Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines

Paul-henri Lambert, Fernanda Tavares

Vaccine, 2013

View PDFchevron_right

A Vaccine Study Design Selection Framework for the Postlicensure Rapid Immunization Safety Monitoring Program

Alison Kawai

American journal of epidemiology, 2015

View PDFchevron_right

Statistical considerations for vaccine immunogenicity trials

George Carlone

Vaccine, 2005

View PDFchevron_right

Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring

Sujatro Chakladar

Biometrics, 2021

View PDFchevron_right

Considerations for the design of vaccine efficacy trials during public health emergencies

Ximena Riveros

2018

View PDFchevron_right

Assessing vaccine durability in randomized trials following placebo crossover

Dean Follmann

Statistics in Medicine, 2021

View PDFchevron_right

Optimal response and covariate-adaptive biased-coin designs for clinical trials with continuous multivariate or longitudinal responses

Anthony Atkinson

Computational Statistics & Data Analysis

View PDFchevron_right

Estimation of vaccine efficacy in a repeated measures study under heterogeneity of exposure or susceptibility to infection

James Maguire

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 2008

View PDFchevron_right

Hypotheses Tests of Strain-specific Vaccine Efficacy Adjusted for Covariate Effects

Yanqing Sun

Journal of Applied Statistics, 2007

View PDFchevron_right

Causal Measures of the Treatment Effect Captured by Candidate Surrogate Endpoints

Manabu Kuroki

Journal of Agricultural, Biological, and Environmental Statistics, 2015

View PDFchevron_right

New approaches to the assessment of vaccine herd protection in clinical trials

Sunheang Shin

Lancet Infectious Diseases, 2011

View PDFchevron_right

Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies

Jennifer Nelson

Journal of Biometrics & Biostatistics, 2012

View PDFchevron_right

The comparison of designs for sequential clinical trials with covariate information

Anthony Atkinson

Journal of the Royal Statistical Society: Series A (Statistics in Society), 2002

View PDFchevron_right